John Livingstone Bio

John Livingstone is a nationally recognized first-chair trial lawyer focusing on complex pharmaceutical, chemical, and biotechnology patent litigation before U.S. district courts, the U.S. International Trade Commission (ITC), and the U.S. Court of Appeals for the Federal Circuit. He also serves as lead counsel in post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO). John was resident in Finnegan’s Tokyo office, the managing partner of the firm’s Atlanta office, and currently sits on the firm’s Management Committee and Diversity, Equity & Inclusion (DEI) Committee. John regularly leads litigation teams in district court and ITC proceedings involving complex patent litigation, trade secret misappropriation, and claims related thereto. In addition to his litigation practice, John represents clients in post-grant proceedings before the PTAB and advises clients on a variety of patent matters, including strategic portfolio management and due diligence assessments in connection with mergers and acquisitions and in-licensing opportunities. John routinely lectures about patent law, including as an adjunct professor at Emory University School of Law teaching a course on patent litigation. He has written numerous legal and scientific articles and presents to national and international audiences, including the International Association for the Protection of Intellectual Property (AIPPI) in Singapore and Seoul; LexisNexis in Shenzhen; Japan Licensing Executive Society (JLES) in Tokyo; Japan Patent Attorneys Association (JPAA) in Tokyo, Osaka, and Shikoku; American Intellectual Property Law Association’s (AIPLA) Chemical Prosecution Bootcamp in Minneapolis and Houston, and Chemical Practice Group meeting in Houston; and Managing Intellectual Property’s (MIP) roundtable in Tokyo. John has been recognized as an “IP Star” and “Patent Star” both nationally and regionally by MIP since 2013 and as a litigation star by Benchmark Litigation. He has ranked among the top U.S. patent lawyers in Legal Media Group’s Guide to the World’s Leading Patent Law Practitioners since 2016. John is recognized by LMG Life Sciences as General Patent Litigator of the Year South, as an Intellectual Property: Life Sciences Star, and for his contributions to “Hatch-Waxman Patent Litigation”. Intellectual Asset Management (IAM) also praised John for his practice in Georgia. He led the litigation teams responsible for the firm’s appellate victory in Kaken Pharmaceutical Co., Ltd.; Bausch Health Care v. Andrei Iancu and district court win in AstraZeneca AB v. Aurobindo Ltd et al., both of which were selected as Impact Cases of the Year at the LMG Life Sciences Awards.